-
TCBP Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
TC Biopharm (TCBP)
Company Profile
Quarter (USD) | Mar 24 | Dec 23 | Dec 22 | Dec 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | |
---|---|---|---|---|
Revenue | ||||
Cost of revenue | ||||
Operating income | ||||
Operating margin | ||||
Net income | ||||
Net profit margin | ||||
Cash on hand | ||||
Change in cash | ||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 980.96 k | 980.96 k | 980.96 k | 980.96 k | 980.96 k | |
Cash burn (monthly) | (no burn) | 1.15 mm | 286.80 k | 802.86 k | 200.72 k | |
Cash used (since last report) | n/a | 11.46 mm | 2.87 mm | 8.02 mm | 2.01 mm | |
Cash remaining | n/a | -10.48 mm | -1.88 mm | -7.04 mm | -1.02 mm | |
Runway (months of cash) | n/a | -9.1 | -6.6 | -8.8 | -5.1 |
13F holders | Current |
---|---|
Total holders | 11 |
Opened positions | 8 |
Closed positions | 1 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 11.95 mm |
Total shares | 4.19 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Alta Partners | 2.93 mm | $6.20 mm |
Kepos Capital | 470.59 k | $6.00 k |
Renaissance Capital Partners | 382.96 k | $1.80 mm |
Nantahala Capital Management | 235.29 k | $2.94 mm |
MEDINET | 73.50 k | $0.00 |
Susquehanna International | 37.61 k | $504.00 k |
Virtu Financial | 24.66 k | $0.00 |
Citadel Advisors | 19.18 k | $257.00 k |
Altium Capital Management | 18.82 k | $235.00 k |
BAC Bank of America | 382.00 | $5.00 k |